Eli Lilly (LLY)
(Delayed Data from NYSE)
$862.86 USD
+18.36 (2.17%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $864.09 +1.23 (0.14%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
LLY 862.86 +18.36(2.17%)
Will LLY be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for LLY
Company News for Oct 31, 2025
Lilly Beats on Q3 Earnings, Ups View, Mounjaro, Zepbound Drive Sales
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Earnings Data Deluge
Pre-markets Down on Questions: Fed, Jobs & Q3 Earnings
Compared to Estimates, Lilly (LLY) Q3 Earnings: A Look at Key Metrics
Other News for LLY
Eli Lilly (LLY) Surges on Strong Q3 Results and Upgraded 2025 Outlook
Notable healthcare headlines for the week: UNH, Eli Lilly and Merck in focus
Top 15 High-Growth Dividend Stocks For November 2025
MACD Bullish Signal Line Cross appears for LLY after 2.17% move
Eli Lilly Reports Strong Q3 2025 Growth